Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Statin Cessation in Patients Aged 75+ (SITE)
NCT02547883Completed
- Sponsor
- Centre Hospitalier Universitaire de Bordeaux
- Start
- Jun 2016
- Primary completion
- Jan 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of ulinastatin in cardiovascular disease (CVD), sponsored by Centre Hospitalier Universitaire de Bordeaux. Primary endpoints: Incremental Cost per QALY gained at 36 months and Overall mortality at 36 months. Started Jun 2016; status: completed.
02
Drugs
ulinastatin
03
Conditions
cardiovascular disease (CVD)
Beyond the preview
Go deeper on NCT02547883.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02547883.